Market Data
Market Cap₹1,809.55 Cr.
52W High₹359
Current Price₹347.45
52W Low₹224.1
Down from 52W High3.2 %
Face Value₹2
Performance
ROCE16.58 %
ROE14.62 %
EPS (TTM)₹2.5
EPS Prev Qtr₹1.21
EPS Last Year₹1.73
EBITDA Qtr₹19.16 Cr.
Book Value₹47
Financial Health
Debt/Equity0.53
Debt/Profit3.72
Total Assets₹448.12 Cr.
Dividend Yield0.14 %
Promoter Holding49.1 %
Earning Power13.13 %
Valuation
Stock P/E50.5
Industry P/E40.99
Price to Book7.39
Price to Sales5.56
Graham Number₹85.31
Key Metrics
Face Value
₹2
About Suraksha Diagnostic Ltd
Healthcare · Healthcare
Suraksha Diagnostic Ltd is listed on NSE in the Healthcare / Healthcare sector. Face value ₹2. Market cap ₹1,809.55 Cr.
Price Chart
Strengths & Weaknesses
Strengths
- The company has a strong ROCE of 28.65%, indicating efficient use of capital.
- ROE stands at 16.61%, reflecting good return generation for shareholders.
- Low debt to equity ratio of 0.03 suggests a conservative capital structure with minimal financial risk.
- Promoter holding of 49.1% indicates significant management control and alignment of interests.
Weaknesses
- The P/E ratio of 47.65 is relatively high, suggesting the stock may be overvalued compared to peers.
- P/B ratio of 8.08 is elevated, indicating potential overvaluation in terms of book value.
- Dividend yield is very low at 0.15%, offering limited income to investors.
Peer Comparison
| Name | CMP | P/E | Market Cap | Div Yield | NP Qtr | Qtr Profit Var% | Sales Qtr | Qtr Sales Var% | ROCE% | Debt/Eq |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | - | 60.97 | ₹1,27,421.96 Cr | 0.23% | ₹2,172 Cr | - | ₹26,429.9 Cr | - | 22.05% | 0.6 |
| Max Healthcare Institute Ltd | - | 66.77 | ₹97,411.97 Cr | 0.2% | ₹1,457.4 Cr | - | ₹8,712.05 Cr | - | 14.38% | 0.27 |
| Manipal Health Enterprises Ltd | - | - | ₹94,970.23 Cr | - | - | - | - | - | - | 1.25 |
| Aster DM Quality Care Ltd | - | 121 | ₹65,183.66 Cr | 0.4% | ₹362.82 Cr | - | ₹4,876.03 Cr | - | 12.95% | 0.17 |
| Fortis Healthcare Ltd | - | 59.91 | ₹62,782.32 Cr | 0.12% | ₹1,070.21 Cr | - | ₹9,506.15 Cr | - | 13.34% | 0.29 |
| Global Health Ltd | - | 69.27 | ₹38,550.84 Cr | - | ₹552.33 Cr | - | ₹4,683.41 Cr | - | 21.87% | 0.1 |
| Narayana Hrudayalaya Ltd | - | 45.26 | ₹37,159.95 Cr | - | ₹816.55 Cr | - | ₹9,072.4 Cr | - | 13.65% | 1.07 |
| Dr Lal Pathlabs Ltd | - | 46.81 | ₹32,548.55 Cr | 1.26% | ₹546.3 Cr | - | ₹2,890.8 Cr | - | 29.55% | 0 |
| Krishna Institute of Medical Sciences Ltd | - | 150.24 | ₹32,180.9 Cr | - | ₹194.4 Cr | - | ₹4,212.5 Cr | - | 9.66% | 1.44 |
| Poly Medicure Ltd | - | 52.64 | ₹16,587.48 Cr | 0.21% | ₹312.92 Cr | - | ₹1,997.43 Cr | - | 15.07% | 0.06 |
| Dr Agarwals Health Care Ltd | - | 107.57 | ₹15,991.79 Cr | - | ₹185.1 Cr | - | ₹2,206.68 Cr | - | 16.46% | 0.08 |
| Vijaya Diagnostic Centre Ltd | - | 82.27 | ₹15,431.94 Cr | 0.13% | ₹187.49 Cr | - | ₹857.13 Cr | - | 36.21% | 0 |
| Syngene International Ltd | - | 68.32 | ₹15,167.87 Cr | 0.33% | ₹221 Cr | - | ₹3,600.2 Cr | - | 6.95% | 0 |
| Indegene Ltd | - | 36.68 | ₹14,769.29 Cr | 0.37% | ₹400.9 Cr | - | ₹3,812.8 Cr | - | 17.45% | 0 |
| Rainbow Childrens Medicare Ltd | - | 48.85 | ₹13,947.12 Cr | 0.25% | ₹290.28 Cr | - | ₹1,820.14 Cr | - | 27.05% | 0 |
| Molbio Diagnostics Ltd | - | - | ₹13,924.73 Cr | - | - | - | - | - | - | 0.35 |
| Park Medi World Ltd | - | 38.3 | ₹11,945.05 Cr | - | ₹296.75 Cr | - | ₹1,756.29 Cr | - | 19.17% | 0.11 |
| Metropolis Healthcare Ltd | - | 24.51 | ₹11,863.54 Cr | 0.87% | ₹202.82 Cr | - | ₹1,710 Cr | - | 19.8% | 0.01 |
| Yatharth Hospital & Trauma Care Services Ltd | - | 58.5 | ₹10,596.57 Cr | - | ₹174.45 Cr | - | ₹1,334.1 Cr | - | 11.7% | 0.14 |
| Healthcare Global Enterprises Ltd | - | 446.68 | ₹10,336.94 Cr | - | ₹33.26 Cr | - | ₹2,627.35 Cr | - | 9.41% | 0.68 |
Quarterly Results
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales | 78.73 | 77.69 | 81.41 | 87.65 |
| ↳ QoQ Growth | - | -1.3% | +4.8% | +7.7% |
| Expenses | 64.76 | 65.09 | 68.3 | 68.49 |
| Operating Profit | 13.97 | 12.6 | 13.11 | 19.16 |
| OPM % | 17.74% | 16.22% | 16.1% | 21.86% |
| Other Income | 0.85 | 0.62 | 0.79 | 1.09 |
| Interest | 2.78 | 3.16 | 3.92 | 3.72 |
| Depreciation | 10.14 | 10.56 | 11.26 | 11.28 |
| EBITDA | 24.11 | 23.16 | 24.37 | 30.44 |
| EBITDA Margin % | 30.62% | 29.81% | 29.93% | 34.73% |
| Profit Before Tax | 12.05 | 10.06 | 9.98 | 16.53 |
| Tax % | 26.72% | 28.03% | 38.28% | 22.26% |
| Net Profit | 8.83 | 7.24 | 6.16 | 12.85 |
| ↳ QoQ Growth | - | -18.0% | -14.9% | +108.6% |
| EPS | 1.73 | 1.44 | 1.21 | 2.5 |
Balance Sheet
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 10.4162 | 10.42 |
| Reserves | 200.8235 | 234.43 |
| Borrowings | 5.83 | 130.34 |
| Other Liabilities | 116.45 | 72.93 |
| Total Liabilities | 333.5242 | 448.12 |
| Fixed Assets | 223.4207 | 309.63 |
| CWIP | 10.0993 | 35.12 |
| Investments | 1 | 0 |
| Other Assets | 99 | 103.37 |
| Total Assets | 333.5242 | 448.12 |
Cash Flows
| Mar 2025 | |
|---|---|
| Cash from Operating Activity | 63.3591 |
| Cash from Investing Activity | -39.5841 |
| Cash from Financing Activity | -24.0482 |
| Net Cash Flow | -0.2732 |
Shareholding Pattern
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters % | 48.98% | 49% | 49.1% | 49.1% |
| FIIs % | 13.72% | 13.46% | 13.46% | 13.47% |
| DIIs % | 21.98% | 22.57% | 23.14% | 23.22% |
| Public % | 12.96% | 12.6% | 12.08% | 11.94% |
| No. of Shareholders | 75,304 | 70,963 | 67,107 | 64,866 |
Major Shareholders (>1%)
- Ritu MittalPromoter and Promoter Group15.93%
- Orbimed Asia Ii Mauritius LimitedPublic Shareholding12.88%
- Satish Kumar VermaPromoter and Promoter Group10.84%
- Sarla KejriwalPromoter and Promoter Group9.23%
As of 2026-06-30View all shareholders →